Eribulin
An analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity. Eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression. [ ]
Term info
Eribulin
- 2-(3-Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4H)-one
- ER-086526
- ERIBULIN
- Eribulin
NCIT_C128784, NCIT_C63923, NCIT_C157711, NCIT_C157712
Breast Cancer
253128-41-5
CHEBI:63587
C40H59NO11
LR24G6354G
http://purl.obolibrary.org/obo/NCIT_C26644
http://purl.obolibrary.org/obo/NCIT_C17219
Eribulin
Pharmacologic Substance, Organic Chemical
C2350866
C96748
Term relations
- Vinca-Domain Binding Agent
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Microtubule Process
- Chemical_Or_Drug_Affects_Gene_Product some Tubulin
- Chemical_Or_Drug_Has_Physiologic_Effect some Positive Regulation of Apoptosis
- Chemical_Or_Drug_Has_Physiologic_Effect some Negative Regulation of Cell Cycle